Evogene (EVGN) Tops Q2 EPS by 19c
Tweet
Share
E-mailGet Alerts EVGN Hot Sheet
Join SI Premium – FREE
Evogene (NASDAQ: EVGN) reported Q2 EPS of ($1.06), $0.19 better than the analyst estimate of ($1.25). Revenue for the quarter came in at $914 thousand versus the consensus estimate of $775 thousand.
For earnings history and earnings-related data on Evogene (EVGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Honeywell wins $53.9M Navy contract for navigation parts
- Leidos wins $85m Air Force contract for aerospace design
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
